Evidence map›Paper›PMID 38136375›Full record

ArticleCancers2023

Health Related Quality of Life in Patients with Bladder Cancer Receiving a Radical Cystectomy.

Riccardo Mastroianni, Andrea Iannuzzi, Alberto Ragusa, Gabriele Tuderti, Mariaconsiglia Ferriero, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Leonardo Misuraca, Simone D'Annunzio and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Riccardo MastroianniDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0003-3708-2209
Andrea IannuzziDepartment of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.ORCID 0000-0003-2619-7465
Alberto RagusaDepartment of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.ORCID 0000-0001-9765-0947
Gabriele TudertiDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0003-4480-9090
Mariaconsiglia FerrieroDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.
Umberto AnceschiDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.
Alfredo Maria BoveDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0002-5139-9993
Aldo BrassettiDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.
Leonardo MisuracaDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.
Simone D'AnnunzioDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.
Salvatore GuaglianoneDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.
Rocco PapaliaDepartment of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.ORCID 0000-0001-9566-7243
Giuseppe SimoneDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0002-4868-9025
Istituti di Ricovero e Cura a Carattere Scientifico · ITCampus Bio Medico University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radical Cystectomy (RC) and Urinary Diversion (UD) is a complex surgery associated with a significant impact on health-related quality of life (HRQoL). However, HRQoL assessment is too often overlooked, with survival and complications being the most commonly investigated outcomes. This study aimed to identify the most impaired HRQoL features in patients receiving RC, compared to a healthy population (HP) control, as well as patients' recovery after surgery, differentiating between patients receiving ORC and RARC. Patients with Bca, who were candidates for RC with curative intent, were enrolled in the "BCa cohort". HRQoL outcomes were collected with an EORTC QLQ-C30 questionnaire. These were collected at baseline, and then at 6-, 12- and 24 mo after surgery in the BCa cohorts, and at baseline in the HP cohort. A 1:1 propensity score matched (PSM)-analysis, adjusted for age, Charlson Comorbidity Index (CCI) and smoking history, was performed. Between January 2018 and February 2023, a total of 418 patients were enrolled in the study, 116 and 302 in the BCa and HP cohorts, respectively. After applying the 1:1 propensity scored match (PSM) analysis, two homogeneous cohorts were selected, including 85 patients in each group. Baseline HRQoL assessment showed a significant impairment in terms of emotional and cognitive functioning, appetite loss and financial difficulties for the BCa cohort. Among secondary outcomes, we investigated patients' recovery after RC and UD, comparing HRQoL outcome questionnaires between the HP and BCa cohorts at 6-, 12- and 24 mo after surgery, and a subgroup analysis was performed differentiating between patients receiving ORC and RARC with totally intracorporeal UD. Interestingly, ORC compared to RARC provided a major impact on HRQoL recovery across the early, mid and long term. In particular, the ORC cohort experienced a major impairment in terms of symptoms scales items such as fatigue, nausea and vomiting, pain and appetite loss. Consequently, comparing ORC and RARC vs. HP reported a major HRQoL impairment in the ORC cohort, possibly defining a benefit of RARC in early, mid- and long-term recovery. To conclude, this study confirmed the undeniable impact of RC on HRQoL. Interestingly, we highlighted the benefit of RARC in early, mid- and long-term recovery, expressed as less impairment of symptoms scales.

Indexed as

bladder cancerHealth-Related Quality of Lifeminimally invasive surgeryopen radical cystectomyradical cystectomyrobotic surgery

Identifiers

PMID38136375
PMCPMC10741964
OpenAlexW4389670008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.